Antiboyd against N-terminal peptide or C-terminal peptide of GPC3 solubilized in blood

Details for Australian Patent Application No. 2008246259 (hide)

Owner Kaisha, C.

Inventors Aburatani, Hiroyuki; Ohizumi, Iwao; Nakano, Kiyotaka; Tokita, Susumu; Ito, Yukio; Midorikawa, Yutaka

Agent FB Rice

Pub. Number AU-B-2008246259

Parent 2003261941

Filing date 20 November 2008

Wipo publication date 11 December 2008

Acceptance publication date 20 September 2012

International Classifications

C12N 15/06 Mutation or genetic engineering - Animal cells

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/08 Mutation or genetic engineering - Cells resulting from interspecies fusion

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

4 December 2008 Complete Application Filed

11 December 2008 Application Open to Public Inspection

  Published as AU-B-2008246259

20 September 2012 Application Accepted

  Published as AU-B-2008246259

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008246260-Apparatus and method for preventing adhesions between an implant and surrounding tissues

2008246258-Antibody against N-terminal peptide or C-terminal peptide of GPC3 solubilized in blood